p120RasGAP-mediated activation of c-Src is critical for oncogenic ras to induce tumor invasion

Cancer Research

Volumn 72, Issue 9, 2012, Pages 2405-2415

  Chan, Po Chao ^a,c   Chen, Hong Chen ^a,b,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INCIDENCE; CANCER INVASION; CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE RAS; ONCOGENE SRC; P120RASGAP GENE; PRIORITY JOURNAL;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CRICETINAE; DOGS; ENZYME ACTIVATION; GOLGI APPARATUS; HEK293 CELLS; HUMANS; MICE; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; P120 GTPASE ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-TYROSINE KINASES; RAF KINASES; RAL GTP-BINDING PROTEINS; RAS PROTEINS; REACTIVE OXYGEN SPECIES; TRANSFECTION;

EID: 84860535263     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3078     Document Type: Article

References (33)

1. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007;7:295-308. (Pubitemid 46480970)
2. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167-80. (Pubitemid 40215811)
3. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003;3:459-65. (Pubitemid 37328850)
4. Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 2006;24:771-800.
5. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 2006;444:724-9. (Pubitemid 44949596)
6. Onken B, Wiener H, Philips MR, Chang EC. Compartmentalized signaling of Ras in fission yeast. Proc Natl Acad Sci U S A 2006;103:9045-50. (Pubitemid 43902530)
7. Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol 2001;2:467-75.
8. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13:513-609. (Pubitemid 28034534)
9. Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997;385:595-602. (Pubitemid 27087566)
10. Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009;6:587-95.
11. van der Geer P, Wiley S, Gish GD, Pawson T. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr Biol 1996;6:1435-44. (Pubitemid 27012242)
12. Tokumitsu Y, Nakano S, Ueno H, Niho Y. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras. J Cell Physiol 2000;183:221-7. (Pubitemid 30185940)
13. Tseng YS, Tzeng CC, Chiu AW, Lin CH, Won SJ, Wu IC, et al. Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil. Exp Cell Res 2003;288:403-14. (Pubitemid 36959956)
14. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54. (Pubitemid 34716871)
15. Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, Lafarga M, et al. Differences on the inhibitory specificities of H-Ras, KRas, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 2003;278:4572-81. (Pubitemid 36800954)
16. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 2002;4:343-50. (Pubitemid 34521029)
17. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-Xl on mitochondria and induces apoptosis. Mol Cell 2006;21:481-93. (Pubitemid 43228004)
18. Cross FR, Garber EA, Pellman D, Hanafusa H. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol Cell Biol 1984;4:1834-42. (Pubitemid 14008294)
19. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649-52. (Pubitemid 27120541)
20. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-69. (Pubitemid 27169285)
21. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3:11-22. (Pubitemid 37328883)
22. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 1997;89:457-67. (Pubitemid 27220890)
23. de Ruiter ND, Wolthuis RM, van Dam H, Burgering BM, Bos JL. Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway. Mol Cell Biol 2000;20:8480-8.
24. Miao W, Eichelberger L, Baker L, Marshall MS. p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues. J Biol Chem 1996;271:15322-9. (Pubitemid 26225297)
25. Clark GJ, Westwick JK, Der CJ. p120 GAP modulates Ras activation of Jun kinases and transformation. J Biol Chem 1997;272:1677-81. (Pubitemid 27043252)
26. Drugan JK, Rogers-Graham K, Gilmer T, Campbell S, Clark GJ. The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain. J Biol Chem 2000;275:35021-7.
27. Pomerance M, Thang MN, Tocque B, Pierre M. The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. Mol Cell Biol 1996;16:3179-86. (Pubitemid 26161315)
28. Bryant SS, Briggs S, Smithgall TE, Martin GA, McCormick F, Chang JH, Parsons SJ, Jove R. Two SH2domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein. J Biol Chem 1995;270:17947-52.
29. Weller SG, Capitani M, Cao H, Micaroni M, Luini A, Sallese M, et al. Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2. Proc Natl Acad Sci U S A 2010;107:5863-8.
30. Gill DJ, Chia J, Senewiratne J, Bard F. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol 2010;189:843-58.
31. Julien S, Adriaenssens E, Ottenberg K, Furlan A, Courtand G, Vercoutter-Edouart AS, et al. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology 2006;16:54-64. (Pubitemid 43009808)
32. Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinomaassociated antigen, and facilitates cell-cell adhesion. Glycobiology 2003;13:521-7. (Pubitemid 36850125)
33. Shields DJ, Murphy EA, Desgrosellier JS, Mielgo A, Lau SK, Barnes LA, et al. Oncogenic Ras/Src cooperativity in pancreatic neoplasia. Oncogene 2011;30:2123-34.